Downregulation of Plk1 expression by receptor-mediated uptake of antisense oligonucleotide-loaded nanoparticles.
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerPolo-like kinase and its inhibitors: Ready for the match to start?Neoplasia: the second decade.Cytotoxicity and cellular uptake of tri-block copolymer nanoparticles with different size and surface characteristicsUpregulated Polo-Like Kinase 1 Expression Correlates with Inferior Survival Outcomes in Rectal CancerOverexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients.The War on Cancer rages on.Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy.Antitumoral effect of PLK-1-inhibitor BI2536 in combination with cisplatin and docetaxel in squamous cell carcinoma cell lines of the head and neck.ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.Targeted delivery of PLK1-siRNA by ScFv suppresses Her2+ breast cancer growth and metastasis.Albumin nanoshell encapsulation of near-infrared-excitable rare-Earth nanoparticles enhances biocompatibility and enables targeted cell imaging.Polo-like kinase 1 as predictive marker and therapeutic target for radiotherapy in rectal cancer.Uptake of plasmid-loaded nanoparticles in breast cancer cells and effect on Plk1 expression.Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel.Systemic siRNA Delivery via Peptide-Tagged Polymeric Nanoparticles, Targeting PLK1 Gene in a Mouse Xenograft Model of Colorectal Cancer.Targeting the cell cycle in esophageal adenocarcinoma: an adjunct to anticancer treatmentThe balance of Polo-like kinase 1 in tumorigenesis.Recent progress in oligonucleotide therapeutics: antisense to aptamers.
P2860
Q24628746-4C8BBBF6-F7B5-4389-8A64-896C4351DE7EQ28087433-A5D1BE6A-5D2C-4351-87FA-9B70A21965BCQ30484000-79294302-C35B-4AEF-8BF0-0F43D8721703Q34251855-7F4B65B9-B1D8-423B-8E52-B0F94870BE3DQ35654260-48EB48BD-4859-4122-A0A1-54019018858AQ37335160-3F9BFEDF-821D-41C0-9361-E72235222E67Q37478602-67D41C80-049F-47C3-966D-9DE14A7578D5Q37776652-F3452EF4-FBF6-4694-AFCE-E4991309B752Q38292744-1FCA8A8E-D23D-4B2E-8FC7-BC5D919A485BQ38982783-6B29CDE0-661F-47B3-8647-D945525FB033Q39361870-B26F21D4-2D62-4E78-880D-8402F96F1535Q39687300-E4A037D6-9D6C-4E85-8169-10426B56E6F4Q39687832-FD8CF5B5-D0FA-4747-8D50-4CE1C29B74DDQ39826698-46CD3D7F-BA5D-47AE-A78D-FA28A9D4731EQ39841379-E35D8377-B9EE-488A-85D8-7739167D1471Q42088063-2BCA7096-995D-4485-9EBE-95802FC6BA1AQ42723757-32BEE2BB-02F4-4536-9E4E-944B9E82E399Q43180721-1E705A3D-2732-4097-9749-AD5BE1CF72F7Q47563314-872CDBF6-AC88-4899-B8A4-75849A1BE5AE
P2860
Downregulation of Plk1 expression by receptor-mediated uptake of antisense oligonucleotide-loaded nanoparticles.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Downregulation of Plk1 express ...... cleotide-loaded nanoparticles.
@en
type
label
Downregulation of Plk1 express ...... cleotide-loaded nanoparticles.
@en
prefLabel
Downregulation of Plk1 express ...... cleotide-loaded nanoparticles.
@en
P2093
P2860
P356
P1433
P1476
Downregulation of Plk1 express ...... cleotide-loaded nanoparticles.
@en
P2093
Birgit Spänkuch
Elisabeth Kurunci-Csacsko
Heidrun Wartlick
Isabel Steinhauser
Klaus I Strebhardt
Klaus Langer
P2860
P304
P356
10.1593/NEO.07916
P577
2008-03-01T00:00:00Z